Press Releases

Trinity Biotech Announces Withdrawal of Troponin FDA 510(k) Submission

Trinity Biotech Announces Q2 2016 Financial Results

Trinity Biotech to Announce Q2 2016 Financial Results

Trinity Biotech Announces Q1 2016 Financial Results

April 19, 2016

Trinity Biotech Announces Q4 and FY 15 Financial Results

March 3, 2016

Trinity Biotech Announces FDA Submission of High Sensitivity Troponin I Product

Trinity Biotech Announces Q3 2015 Financial Results

October 23, 2015 Download

Trinity Biotech to Announce Q3 2015 Financial Results

October 13, 2015 Download

Trinity Biotech Announces Q2 2015 Financial Results

July 28, 2015 Download

Trinity Biotech Launches Redesigned Website

July 23, 2015

Meet Trinity Biotech and Immco Diagnostics at AACC 2015 at booth 1007

June 4, 2015

Trinity Biotech Announces Q1 2015 Financial Results

April 30, 2015 Download

Trinity Biotech to exhibit at ECCMID 2015 in Copenhagen

April 1, 2015

Trinity Biotech Announces Q4 and FY 2014 Financial Results

March 3, 2015 Download

Immco Diagnostics to participate at the 2015 International Congress on Controversies in Rheumatology and Autoimmunity (CORA)

February 17, 2015

Trinity Biotech Announces CLIA waiver of Rapid Syphilis Test

December 16, 2014

Trinity Biotech and Immco Diagnostics to exhibit at Arab Health 2015

December 12, 2014

Trinity Biotech Announces CE Marking of New Meritas Heart Failure (BNP) Point-of-Care Test

September 25, 2014

Trinity Biotech announces CE marking of Uni-Gold™ H. pylori Antigen point of care test

July 1, 2014